P/E ratio for SurModics (SRDX)
P/E ratio as of May 2024 (TTM): -15.6
According to SurModics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -15.5697. At the end of 2022 the company had a P/E ratio of -14.7.
P/E ratio history for SurModics from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -14.7 | -103.97% |
| 2021 | 370 | -57.45% |
| 2020 | 870 | 908.43% |
| 2019 | 86.3 | -120.09% |
| 2018 | -430 | |
| 2016 | 34.8 | 63.07% |
| 2015 | 21.3 | -15.04% |
| 2014 | 25.1 | 5.03% |
| 2013 | 23.9 | -23% |
| 2012 | 31.1 | -218.63% |
| 2011 | -26.2 | 193.32% |
| 2010 | -8.92 | -127.57% |
| 2009 | 32.4 | 161.33% |
| 2008 | 12.4 | -96.12% |
| 2007 | 319 | 1007.89% |
| 2006 | 28.8 | -131.16% |
| 2005 | -92.5 | -242.23% |
| 2004 | 65.0 | 149.23% |
| 2003 | 26.1 | -54.52% |
| 2002 | 57.4 | -35.5% |
| 2001 | 88.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.3 | -165.93% | 🇺🇸 USA |
 Abbott Laboratories ABT | 35.7 | -328.99% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 37.1 | -338.12% | 🇺🇸 USA |
 Agilent Technologies A | 35.8 | -329.81% | 🇺🇸 USA |
 PerkinElmer
PKI | 15.0 | -196.13% | 🇺🇸 USA |
 Alkermes ALKS | 18.9 | -221.24% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | -0.8957 | -94.25% | 🇺🇸 USA |
 Heron Therapeutics HRTX | -1.98 | -87.26% | 🇺🇸 USA |
 Enzo Biochem ENZ | -1.11 | -92.89% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.